Phase I Clinical Trial Candidates
Showing 1 - 25 of >10,000
Monkeypox Trial (BNT166a, BNT166c)
Not yet recruiting
- Monkeypox
- BNT166a
- BNT166c
- (no location specified)
Aug 4, 2023
Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)
Not yet recruiting
- Malaria
- +4 more
- RH5.1 and/or RH5.2-VLP with Matrix-M
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023
Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
-
Darlinghurst, Australia
- +55 more
Dec 28, 2022
Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)
Recruiting
- Covid19
- CST-2: EIDD-2801
- +6 more
-
Cape Town, South Africa
- +5 more
Aug 9, 2022
Atopic Dermatitis, Atopic Hand Eczema Trial (Tralokinumab, Placebo)
Not yet recruiting
- Atopic Dermatitis
- Atopic Hand Eczema
- Tralokinumab
- Placebo
- (no location specified)
Jul 13, 2023
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2 (Omi XBB.1.5)
-
Dublin, California
- +14 more
Aug 10, 2023
Advanced Malignant Tumor Trial (SHR-5495 for injection)
Not yet recruiting
- Advanced Malignant Tumor
- SHR-5495 for injection
- (no location specified)
Sep 26, 2023
Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)
Not yet recruiting
- Solid Tumor
- Positron-Emission Tomography(PET)
-
Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Aug 4, 2023
Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)
Not yet recruiting
- Non-muscular Invasive Bladder Cancer
- BCG for therapeutic use
-
Changsha, ChinaHunan Cancer Hospital
Oct 20, 2023
Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)
Recruiting
- Influenza, Human
- COVID-19
- bivalent BNT162b2 (original/Omi BA.4/BA.5)
- +2 more
-
Athens, Alabama
- +18 more
Dec 22, 2022
Patients With Advanced Solid Tumors Trial in Beijing (TCC1727 tablet)
Not yet recruiting
- Patients With Advanced Solid Tumors
- TCC1727 tablet
-
Beijing, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Jul 23, 2023
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
Advanced Malignant Tumor Trial (HRS-2189 Tablets)
Not yet recruiting
- Advanced Malignant Tumor
- HRS-2189 Tablets
- (no location specified)
May 6, 2023
CAR-T Trial in Hangzhou (GC012F injection)
Recruiting
- CAR-T
- GC012F injection
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
May 10, 2023
Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-cell Lymphoma
- RC19D2 cell injection
-
Tianjin, Tianjin, ChinaHematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023
Prostate Cancer Trial (HRS-9815 injection)
Not yet recruiting
- Prostate Cancer
- HRS-9815 injection
- (no location specified)
Sep 25, 2023
Hypertension, Dyslipidemias Trial (CKD-348(6), CKD-828, D097, D337)
Not yet recruiting
- Hypertension
- Dyslipidemias
- CKD-348(6)
- CKD-828, D097, D337
- (no location specified)
Oct 29, 2023
Hematologic Malignancy Trial in Tianjin (BR108 injection)
Recruiting
- Hematologic Malignancy
- BR108 injection
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 25, 2023
Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,
Recruiting
- Hand, Foot and Mouth Disease
- Herpangina
- low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
- +3 more
-
Chuxiong, Yunnan, ChinaDayao County Center for Disease Control and Prevention
Sep 25, 2023
Malignant Pleural Effusion Trial in Wuhan (JMKX000197)
Recruiting
- Malignant Pleural Effusion
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 25, 2023
Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)
Not yet recruiting
- Overweight or Obesity
- Xenical® vs EMP 22
- +2 more
-
Uppsala, SwedenCTC Clinical Trial Consultanta AB
Aug 25, 2023